Hms Capital Management, LLC Neogenomics Inc Transaction History

Hms Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$30.49 - $48.49 $361,215 - $574,461	-11,847 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$36.62 - $51.69 $2,197 - $3,101	60 Added 0.51%	11,847 $535,000
Q1 2021 Apr 12, 2021	SELL	$41.56 - $59.88 $123,183 - $177,484	-2,964 Reduced 20.09%	11,787 $567,000
Q3 2020 Oct 20, 2020	SELL	$33.26 - $40.48 $9,379 - $11,415	-282 Reduced 1.88%	14,751 $544,000
Q2 2020 Jul 31, 2020	SELL	$24.21 - $31.02 $8,304 - $10,639	-343 Reduced 2.23%	15,033 $466,000
Q1 2020 Apr 27, 2020	SELL	$20.5 - $34.53 $10,332 - $17,403	-504 Reduced 3.17%	15,376 $425,000
Q3 2019 Oct 15, 2019	BUY	$19.12 - $26.24 $303,625 - $416,691	15,880 New	15,880 $303,000

294

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.16B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Hms Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hms Capital Management, LLC with notifications on news.